Tilray (NASDAQ:TLRY – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02), Briefing.com reports. The company had revenue of $229.90 million for the quarter, compared to analyst estimates of $226.20 million. Tilray had a negative return on equity of 2.65% and a negative net margin of 30.26%. The business’s revenue was up 24.8% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.15) earnings per share.
Tilray Trading Up 0.5 %
NASDAQ:TLRY traded up $0.01 during trading hours on Thursday, hitting $2.04. The company had a trading volume of 15,547,789 shares, compared to its average volume of 26,013,432. Tilray has a 1 year low of $1.60 and a 1 year high of $3.40. The company has a current ratio of 1.92, a quick ratio of 1.18 and a debt-to-equity ratio of 0.11. The company has a 50-day moving average of $1.78 and a 200 day moving average of $1.90. The company has a market cap of $1.58 billion, a P/E ratio of -4.68 and a beta of 2.19.
Analyst Ratings Changes
TLRY has been the topic of several research analyst reports. CIBC lowered their price objective on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a report on Wednesday, April 10th. Canaccord Genuity Group dropped their price target on Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Finally, Alliance Global Partners lifted their target price on shares of Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday, April 5th.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Recommended Stories
- Five stocks we like better than Tilray
- Learn Technical Analysis Skills to Master the Stock Market
- First Solar Stock: The Dawn of a New Rally in Share Prices
- Why Are These Companies Considered Blue Chips?
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- What is the Euro STOXX 50 Index?
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.
